1 Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Nov 03, 2024
3 New Targeted Drug For Leukaemia Approved, 35% Of Patients' Cancer Cells Disappear Completely! Nov 01, 2024
5 Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma Oct 17, 2024
6 Angry FDA & CDC: $5 Billion Bivalent Moderna New Crown Vaccine Not As Effective As Monovalent Oct 06, 2024
Read More Healthy What Exercises Are Suitable For Elderly People With High Blood Pressure Nov 16, 2024
Read More Apparatus Canada has developed a hand-held detector to help reduce the use of antibiotics Nov 11, 2024
Read More Apparatus New Lymphoma Drug Approved! Half Of The Patients Had Significant Tumour Regression Nov 21, 2024
